Vertex Pharmaceuticals
VRTX | NASDAQ
$552.75
-$6.13 (-1.10%)
Nov 2, 2026, 3:56 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 29.32 | -193.61 | 28.96 | 22.27 | 24.16 | 22.64 |
PEG Ratio | -0.03 | 1.69 | 3.48 | 0.52 | -1.87 | 0.18 |
PS Ratio | 9.60 | 9.41 | 10.62 | 8.28 | 7.47 | 9.90 |
PB Ratio | 6.21 | 6.32 | 5.96 | 5.32 | 5.60 | 7.07 |
P/FCF Ratio | 36.30 | -131.21 | 31.98 | 18.84 | 23.50 | 20.51 |
P/OCF Ratio | 31.92 | -210.51 | 29.64 | 17.91 | 21.41 | 18.88 |
OCF/S Ratio | 30.07 | -4.47 | 35.84 | 46.24 | 34.90 | 52.43 |
Debt / Equity Ratio | 0.21 | 0.11 | 0.05 | 0.06 | 0.10 | 0.11 |
Quick Ratio | 2.46 | 2.35 | 3.78 | 4.66 | 4.30 | 4.18 |
Current Ratio | 2.90 | 2.69 | 3.99 | 4.83 | 4.46 | 4.33 |
Asset Turnover | 0.46 | 0.49 | 0.43 | 0.49 | 0.56 | 0.53 |
Interest Coverage | 357.95 | -7.61 | 86.89 | 78.60 | 45.24 | 49.12 |
Return on Equity | 21.18% | -3.26% | 20.59% | 23.88% | 23.19% | 31.22% |
Return on Assets | 15.12% | -2.38% | 15.92% | 18.30% | 17.44% | 23.07% |
Return on Invested Capital | 18.12% | 2.63% | 16.44% | 21.81% | 20.99% | 25.06% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 85.03% | 86.11% | 87.21% | 87.90% | 88.06% | 88.14% |
Net Profit Margin | 32.74% | -4.86% | 36.68% | 37.20% | 30.92% | 43.70% |
Pretax Profit Margin | 38.45% | 2.25% | 44.38% | 47.39% | 36.05% | 50.23% |
Operating Profit Margin | 39.43% | -2.11% | 38.83% | 48.23% | 36.73% | 46.03% |
FCF Margin | 26.45% | -7.17% | 33.22% | 43.95% | 31.80% | 48.24% |
EBITDA Margin | 40.28% | 4.41% | 46.66% | 49.67% | 38.52% | 52.93% |
Add to Watchlist
Select watchlists to add or remove VRTX